Additionally, genetics might also contribute to drug-specific toxic effects, with one study showing that dihydropyrimidine dehydrogenase (DPD) deficiency was associated with reduced clearance of fluoropyrimidines and prolonged exposure [32]. Here, DPYD is linked to hyperinsulinemic hypoglycemia, familial, 4.